NCT02586311View on ClinicalTrials.gov

CKD-330 Phase 3 Trial in Amlodipine Non-responder

PHASE3CompletedINTERVENTIONAL
Enrollment

160

Participants

Timeline

Start Date

January 31, 2016

Primary Completion Date

August 31, 2016

Study Completion Date

September 30, 2016

Conditions
Hypertension
Interventions
DRUG

CKD-330 16/5mg

Once a day, 8 weeks

DRUG

Amlodipine 5mg Placebo

Once a day, 8 weeks

DRUG

CKD-330 16/5mg Placebo

Once a day, 8 weeks

DRUG

Amlodipine 5mg

Once a day, 8 weeks

Trial Locations (1)

Unknown

Korea University Guro Hospital, Seoul

Sponsors
All Listed Sponsors
lead

Chong Kun Dang Pharmaceutical

INDUSTRY